Behind-The-Counter Sale Is No Deterrent To Brand Loyalty – Survey
This article was originally published in The Tan Sheet
Executive Summary
Behind-the-counter status does not diminish customers' loyalty to brand name nonprescription drugs, according to results of a nationwide survey
You may also be interested in...
In-Store Clinics Could Boost OTCs, But Pose Possible Appearance Of Conflict
The growth of in-store health care clinics could lead to consumers more often opting for OTC products over receiving prescriptions, but also creates the possibility for the appearance of conflicts of interest involving the host retail sites and the clinic operators, health care association executives say
Behind-The-Counter Sale Works Without Regulation – Former FDA Counsel
FDA's interest in establishing an official third class of drugs, as well as the OTC industry's concern about the idea, could be diminished because the agency already allows a path to behind-the-counter sales in new drug and switch applications, according to a former FDA chief counsel
Jurors' Answers In FTC's Prevagen Complaint Might Burst A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.